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Abstract
 .In the epidermal growth factor EGF -receptor signal transduction cascade, the non-receptor tyrosine kinase c-Src has
been demonstrated to become activated upon EGF stimulation. In this paper we show that c-Src associates with the
cytoskeleton and co-isolates with actin filaments upon EGF treatment of NIH-3T3 cells transfected with the EGF receptor.
Immunofluorescence studies using CLSM show colocalization of F-actin and endogenous c-Src predominantly around
endosomes and not on stress fibers and cell–cell contacts. Stimulation of EGF receptor-transfected NIH-3T3 cells with EGF
induces an activation and translocation of c-Src to the cytoskeleton. These processes depend upon the presence of the actin
binding domain of the EGF-receptor since in cells that express EGF-receptors lacking this domain, EGF fails to induce an
activation and translocation to the cytoskeleton of c-Src. These data suggest a role for the actin binding domain of the
EGF-receptor in the translocation of c-Src. q 1997 Elsevier Science B.V.
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1. Introduction
Many components mediating cellular signal trans-
duction cascades are associated to the cytoskeleton.
Two of these molecules are the transmembrane tyro-
 .sine kinase Epidermal growth factor receptor EGF -
receptor and the non-receptor tyrosine kinase c-Src.
EGF stimulation of cells leads to a rapid increase in
w xthe number of cytoskeleton bound EGF-receptors 1
w xand a reorganization of the cytoskeleton 2 , specifi-
) Corresponding author. Fax: 31-30-2511893; E-mail:
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w xcally the actin system 3,4 . We have shown previ-
ously that the EGF-receptor binds directly to actin via
 . w xits actin binding domain ABD 5 and that deletion
of this domain abolishes the direct actin association.
The c-Src proto-oncogene is a non-receptor tyrosine
kinase found in a wide variety of cells. Although the
exact cellular function of c-Src is still unclear, it has
been shown to be involved in signal transduction
processes leading to proliferation and differentiation
w x6–14 . These two tyrosine kinases are functionally
linked since c-Src has been shown to become acti-
w xvated upon EGF stimulation 15–17 . Recently, we
have demonstrated that c-Src associates to the cyto-
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skeleton and EGF stimulation leads to an increase in
cytoskeleton associated c-Src and c-Src activity, simi-
w xlar as for the EGF-receptor 17 . Interestingly, c-Src
has been suggested recently as a regulator of EGF-in-
duced actin reorganization in c-Src overexpressing
w xC3H10T1r2 cells 18 . It might perform this function
by its action on p190RhoGAP, a regulator of the
small GTP-binding protein Rho, which plays a major
w xrole in stress fiber and focal adhesion formation 19 .
Initial studies on the localization of Src were
performed using the viral homologue v-Src. This
protein displays a diffuse intracellular distribution
wand, in addition, is localized in focal adhesions 20–
x24 . Furthermore, the cytoskeletal association, specif-
ically to focal adhesions, of v-Src depends on its SH2
w xand catalytic domain 25,26 . More recently,
immunofluorescence studies revealed that c-Src is
localized at the plasma membrane and perinuclear
w xendosomes 18,23,24,27 . c-Src is myristylated at the
amino terminal glycine residue and this might explain
the colocalization with membranes, since the first 14
amino acids of c-Src, including the myristylation site,
are sufficient to localize chimeric proteins to mem-
w xbranes 28 . However, additional N-terminal se-
quences, amino acids 38–111 and 204–259 including
parts of the SH3 and the SH2 domain, respectively,
are required to obtain plasma membrane and endoso-
w xmal localization 28 . In addition, active c-Src associ-
ates to the cytoskeleton and cytoskeleton bound pro-
 .teins e.g. cortactin or cytoskeleton bound substrates
 . w xe.g. p110 29–34 . The v-Src protein mainly differs
from its cellular homologue by a c-terminal deletion,
which includes the important tyrosine phosphoryla-
tion site Y527, resulting in a constitutively active
kinase domain. Substitution of Y527 for phenyl-
alanine in c-Src, thereby activating the enzyme, re-
sults in focal adhesion localization and in an increase
in cytoskeleton association of c-Src, similar to v-Src
w x24 . While v-Src localization in focal adhesions de-
pends on an intact SH3 domain, focal adhesion local-
ization of this c-Src depends on its SH3 and catalytic
w xdomain 24 . These data demonstrate that native c-Src
distributes differently than the constitutively active
v-Src.
Interestingly, c-Src activation and cytoskeleton as-
w xsociation are probably coupled processes 25 . This
was shown by mutation of Y527, which results in a
more active c-Src together with an increased cyto-
w xskeleton association 24 . Furthermore, v-Src which
lacks a sequence including Y527 is also highly cyto-
skeleton associated and displays a transforming ca-
pacity, which extent correlates with the degree of
w xcytoskeleton association 29,35,35 .
We were intrigued by the observations that EGF
stimulation leads to an activation and translocation of
endogenous c-Src to the cytoskeleton even more,
since the EGF-receptor itself is linked to actin. To
further investigate the molecular mechanism underly-
ing these processes, we first determined if this activa-
tion and translocation depends on the actin associa-
tion of the EGF-receptor itself. For this part we used
a mutant EGF-receptor lacking the ABD and thereby
losing its direct F-actin interaction. Next we wanted
to establish to which component of the cytoskeleton
c-Src associates. From our experiments we conclude
that EGF-induced c-Src-cytoskeleton association de-
pends on the intact ABD of the EGF-receptor. Fur-
thermore, we demonstrate that also the EGF-induced
c-Src activation in the cytoskeletal fraction is abol-
ished by the ABD mutation. We did not find a
correlation between the EGF-induced c-Src-cyto-
skeleton association and EGF-induced transformation
as it was found for the viral homologue, v-Src.
Finally, we found that c-Src associates to actin fila-
ments and that EGF stimulation leads to a rearrange-
ment of both c-Src and F-actin. These rearrangements
are probably linked since both depend on the ABD of
the EGF-receptor.
2. Materials and methods
2.1. Cell culture
  ..NIH-3T3 cells were either non-transfected 3T3 0
or were co-transfected with pSV neo and an SV402
driven expression vector encoding either wildtype
 .EGF-receptors HERc13, HER14 or mutant EGF-re-
ceptors lacking the ABD D12–21, D12–37, amino
.acids 985–996 deleted . Neomycin-resistant clones
were isolated after two to three weeks of G418
 .Sigma selection and screened for EGF-receptor ex-
pression by 125I-EGF binding. The D12 deletion was
created using the ‘‘Altered Sites in vitro mutagenesis
 .system’’ Promega, Madison, WI, USA in combina-
tion with the 37 bp primer 5XGCTGCTGAAGAAGC-
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CCTGGTCCATGTCTTCTTCATCC3X, according to
the procedures of the manufacturer. In non-trans-
 .fected NIH-3T3 cells 3T3 0 cells, we were not able
to measure specific binding of 125I-EGF, neither could
we measure biological responses to EGF in these
 .cells data not shown . Cells were routinely grown in
DME supplemented with 7.5% FCS Gibco, Breda,
.The Netherlands in a humified 7.5% CO atmo-2
sphere at 378C. Culture medium of transfected cells
was supplemented with 250 mgrml G418. Before
EGF stimulation, cells were made quiescent by serum
deprivation for 16 h.
2.2. Subcellular fractionation
Cells were separated in a cytosolrmembrane pro-
tein and a cytoskeletonrnuclei fraction. Cells,
whether or not stimulated with 100 ngrml EGF, were
washed with ice-cold PBS containing 5 mM EDTA
and 100 mM sodium orthovanadate and harvested by
scraping in 800 ml of hypotonic lysis buffer 10 mM
Hepes pH 7.5, 10 mM NaCl, 1 mM KH PO , 5 mM2 4
NaHCO , 1 mM CaCl , 0.5 mM MgCl , 5 mM3 2 2
EDTA, 1% Triton X-100, 10 mM sodium pyrophos-
phate, 1 mM sodium orthovanadate, 1 mM PMSF,
.10 mgrml leupeptin, and 50 unitsrml aprotinin and
incubated for 30 min and then were centrifuged at
50 000=g for 60 min. The insoluble fraction referred
to as the cytoskeleton contains cytoskeleton, mem-
brane skeleton and membrane depleted nuclei. These
pellets were solubilized in 400 ml of RIPA buffer
20 mM Tris–HCl pH 7.5, 150 mM NaCl, 10 mM
NaH PO , 5 mM EDTA, 1 mM dithiothreitol, 10%2 4
glycerol, 1 mM sodium orthovanadate, 1% sodium
deoxycholate, 1% Triton X-100, 0.1% SDS, 1 mM
PMSF, 10 mgrml leupeptin, and 50 unitsrml apro-
.tinin for 30 min, and remaining insoluble material
was removed by centrifugation. Prior to immuno-
precipitation the detergent concentrations in all frac-
tions were adjusted with concentrated RIPA buffer.
2.3. Immune complex kinase assay and immuno-
blotting
Kinase assays were performed as described before
w x17 . In short, c-Src was immunoprecipitated from the
isolated fractions with 5mgrml mAb a327 mono-
clonal antibody producing hybridoma cells were
kindly provided by Dr. Joan S. Brugge, University of
.Pennsylvania . Immune complexes were collected af-
ter overnight incubation with protein A-sepharose
beads by centrifugation at 12 000=g for 5 min. The
beads were washed three times with HNTG buffer
20 mM Hepes pH 7.5, 150 mM NaCl, 0.1% Triton
.X-100, 10% glycerol , supplemented with 1 mM
sodium orthovanadate and once with kinase buffer
containing 20 mM Hepes pH 7.5, 5 mM MgCl , 3 mM2
MnCl , and 1 mM sodium orthovanadate. For autoki-2
nase reactions the final pellets were resuspended in
40 ml of the kinase buffer, warmed to 208C, and
w 33 x incubated with 250 kBq of g- P ATP Amersham,
.Buckinghamshire, UK for 5 min. Kinase reactions
towards enolase were carried out in the presence of
3 mg acid-denatured enolase and additional 3 mM un-
labeled ATP. Phosphorylation reactions were termi-
nated by the addition of 70 ml of preheated 2=
concentrated electrophoresis sample buffer. The sam-
ples were heated at 958C for 5 min and the proteins
separated by SDS–PAGE on 8% gels. Transfer of
proteins to a polyvinylidene difluoride membrane
was performed overnight with a Bio-Rad Trans-Blot
apparatus. Following two rinses in PBS for 5 min, the
filters were blocked in PBS containing 5% BSA
 .fraction V, essentially fatty-acid-free, Sigma for
60 min at room temperature. After washing with PBS,
0.1% BSA, the wet filters were covered with food
wrap and incorporation of 33P was analyzed in a
 .PhosphoImager Molecular Dynamics using the Im-
ageQuant software. The same filters were succes-
 .sively probed with mAb a327 1 mgrml, 16 h and
125 with I-labeled protein A Amersham, Bucking-
.hamshire, UK, 30 kBqrml, 60 min , all diluted in
PBS, 0.1% BSA containing 0.3% Tween 20. Finally,
the filters were washed eight times for 10 min with
PBS, 0.1% BSA, 0.3% Tween 20 and twice for 5 min
with PBS and dried. Quantification of the 125I signal
was performed in the PhosphoImager while shielding
the 33P signal with a plastic covering.
2.4. Soft agar growth assay
Trypsinized cells were resuspended in DME con-
taining 5% FCS with or without EGF and 0.375%
 .  .wrv agar Difco . From this 1.5 ml suspension
containing 1=104 cells, was poured at an underlayer
of 0.5% agar in DME in a 24 cm2 petri dish. Assays
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were performed in duplicate. After 1 to 2 weeks
colonies were scored under a phase contrast micro-
scope at a 10= magnification. Colonies in 20 sepa-
rated, random fields in each dish were counted,
colonies containing less than 10 but more than 6 cells
were scored as 1r2, while colonies of more than 10
cells were scored as 1.
2.5. Isolation of actin filaments and actin co-sedimen-
tation assay
F-actin isolation was essentially performed as de-
w xscribed before 36 , with some modification. Cells,
 .grown in two 145 mm dishes 90% confluency were
washed twice with ice-cold PBS and lysed with 0.5%
Triton X-100 in CSK-buffer for 10 min on ice and
subsequently scraped and transferred to precooled
 .tubes fraction T, total cells . Lysates were cen-
trifuged at 14 000=g for 10 min supernatant, frac-
.tion CMTscytosolqmembrane proteinsq tubulin .
The pellet was further extracted with 0.3 M KI in
CSK-buffer for 5 min on ice and centrifuged at
14 000 = g for 30 min pellet, fraction IN s
.intermediate filamentsqnuclei . Subsequently, the
supernatant was dialyzed against CSK-buffer for 16 h
at 48C. During this dialysis the actin repolymerizes
and can be spun down at 14 000=g for 30 min. The
pellet was resuspended again in 0.3 M KI in CSK-
buffer and incubated for 10 min on ice. The solution
was clarified by centrifugation 14 000 = g for
.30 min and dialyzed against CSK-buffer. The actin
polymers were again spun down at 14 000=g for
30 min and solubilized in CSK-buffer fraction As
.actinqactin binding proteins . Protein fractions were
separated by 10% SDS–PAGE and blotted onto
nitrocellulose Schleicher and Schuell, Dassel, Ger-
.many . Blots were blocked with 2% milkpowder in
PBS containing 0.05% Tween 20 for 45 min at room
temperature. c-Src was detected with mAb a327,
actin was detected with anti-actin antibody N350,
.Amersham, Buckinghamshire, UK , and primary an-
tibodies were detected with Rabbit anti Mouse perox-
idase conjugated secondary antibody Jackson Im-
.muno Research, West Grove, PA, USA . The anti-
bodies were diluted in 0.5% milk powder in PBS
containing 0.05% Tween 20, and the blot was incu-
bated with these antibodies for 60 min. Blots were
washed 6 times with 0.5% milk powder in PBS and
 .detected by enhanced chemiluminescence ECL
 .Amersham, Buckinghamshire, UK . c-Src and actin
signals were quantified on a densitometer Molecular
.Dynamics using the ImageQuant software.
2.6. Immunofluorescence
Cells were grown on coverslips till 50–80% con-
fluency, washed with PBS and subsequently fixed
 .with 3% formaldehyde in PBS pH 7.4 for 30 min at
room temperature. Cells were washed once with PBS,
permeabilized with PBS containing 0.1% Triton X-
100 for 5 min and treated twice with 1 mgrml Na-
borohydride containing PBS for 5 min and subse-
quently twice with PBS containing 0.2% gelatin.
c-Src was labelled with mAb a327 for 60 min in
 .PBS–gelatin 0.2% at room temperature. The anti-
body was specific for c-Src as shown by Western
blotting. Rabbit anti-mouse conjugated with FITC
 .Jackson Immuno Research, West Grove, PA, USA
was used as the secondary antibody. F-actin was
 .labelled with phalloidin-TRITC Sigma during the
secondary antibody incubation. Finally, the cells were
embedded in Mowiol containing 1 mgrml p-phenyl-
 .enediamine Sigma and examined in a CLSM
 .Lasersharp mrc-500, Biorad, Hemel Hempstad, UK .
3. Results
3.1. EGF-receptors lacking the ABD are unable to
translocate c-Src to the cytoskeleton
We hypothesized that the direct EGF-receptor–
actin interaction is involved in an EGF-induced acti-
vation and cytoskeletal translocation of c-Src. To
validate this assumption we used a cell line express-
ing a mutated version of the EGF-receptor. This
receptor is lacking the 12 amino acid long ABD,
from amino acid 984 to 996 and thereby lacks the
direct actin binding capacity. Despite this deletion,
these mutant receptors are capable to bind EGF and
initiating signal transduction processes leading to Shc
recruitment, MAP-kinase and PLC activation, c-fos
 .induction and DNA synthesis data not shown . Qui-
 .escent NIH-3T3 cells expressing wildtype HERc13
 .or the ABD-minus EGF-receptor D12–21 were
stimulated with 100 ngrml EGF for 20 min after
which cytoskeleton fractions were prepared as de-
scribed in Section 2. From this fraction the c-Src was
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Fig. 1. EGF-induced c-Src-cytoskeleton association and activa-
 .tion. A EGF-induced translocation of c-Src to the cytoskeleton
in HERc13 and D12–21 cells. Quiescent HERc13 and D12–21
cells were treated with 100ngrml EGF for 20 min. Cells were
harvested in lysis buffer supplemented with 1% Triton X-100 for
30 min. The 50 000= g pellet of this extraction was solubilized
in RIPA and insoluble remainings were removed. c-Src protein
was immunoprecipitated from this preparation with monoclonal
antibody a327 and analyzed for the amount of c-Src protein by
western blotting using the same antibody and 125I-protein A.
 .  .c-Src and immunoprecipitating antibody IgG are indicated; B
 .subcellular auto kinase activity of c-Src following EGF stimula-
 .  .tion of 3T3 0 , HERc13 and D12–21 cells. Quiescent 3T3 0 ,
HERc13 and D12–21 cells were stimulated with 100ngrml EGF
for 20 min, harvested and lysed as described in the legend of Fig.
 .1 A . Cytoskeleton fractions were prepared and c-Src was im-
munoprecipitated with mAb a327. The immunoprecipitates were
assayed for autophosphorylation and enolase phosphorylation
using 33P-labeled ATP as a phosphate donor. After SDS-PAGE
and transfer of the proteins to PVDF membranes, phosphate
incorporation was determined in a PhosphoImager. The positions
of c-Src and enolase are indicated.
immunoprecipitated and analyzed for the amount of
c-Src by Western blotting and immuno detection.
Subsequently data were quantified on a PhosphoIm-
 .ager. As shown in Fig. 1 A , c-Src is associated to
some extent to the cytoskeleton in non-stimulated
cells, both in HERc13 and D12–21 cells. However,
treatment of the cells with EGF increases the amount
of cytoskeleton associated c-Src in HERc13 wildtype
cells while no increase, and even a small decrease
was observed in D12–21 mutant cells. These data
demonstrate an important role for the ABD of the
EGF-receptor in the translocation of c-Src to the
cytoskeleton.
Fig. 2. c-Src-cytoskeleton association following induction with
increasing EGF concentrations. HERc13 and D12–21 cells were
stimulated with 0, 2, 5, 15, 40 and 100ngrml EGF for 10 min.
Then cells were harvested and prepared for immunoprecipitation
 .as described in the legend of Fig. 1 A . Position of c-Src is
indicated.
To exclude the possibility that we missed the
c-Src-cytoskeleton translocation in D12–21 cells by a
change in ligand-dependency rather than a total block
of translocation we performed stimulation series with
increasing amounts of EGF on HERc13 and D12–21.
Again, we only observe an increase in cytoskeleton
associated c-Src in HERc13 cells emerging at
40 ngrml and reaching the maximum response at a
 .concentration of 100 ngrml EGF Fig. 2 . No in-
crease in c-Src-cytoskeleton association at any EGF
concentration was found in D12–21 cells. Similarly,
no increase in c-Src-cytoskeleton association was
found when D12–21 cells were stimulated with EGF
 .for time periods upto 1 h data not shown .
Table 1
c-Src kinase activity in subcellular fractions upon EGF-stimula-
tion
Cell type Cytosol Cytoskeleton
c-Src Enolase c-Src
auto-kinase act. phosphoryl auto-kinase act.
 .  .  .fold stim fold stim fold stim
 .3T3 0 1.0 1.2 1.1
HERc13 1.1 3.0 2.5
D12–21 0.6 0.5 0.6
Cells were stimulated with 100ngrml EGF for 20 min. c-Src
kinase activity was assessed by quantifying blots for c-Src autoki-
nase activity and enolase phosphorylation. The values are fold
stimulation as compared with the situation in the subcellular
fractions from untreated cells. In cytosol no enolase phosphoryla-
tions were performed.
( )M.A.G. ˝an der Heyden et al.rBiochimica et Biophysica Acta 1359 1997 211–221216
Table 2
Effect of EGF on anchorage-independent growth in cells express-
ing wildtype and D12 EGF-receptors
 .  .Cell yEGF % qEGF % aEGF-receptorsrcell
 .3T3 0 7.7 7.8 -1000
HERc13 0.3 3.2 65 000
HER14 4.2 37.1 250000
D12–37 0.0 2.3 40 000
D12–21 0.8 51.0 120000
Soft agar growth was performed in DME in the presence of 5%
FCS with or without 10ngrml EGF. Colonies were scored after
2 weeks by counting of 20 random fields on a phase contrast
microscope and expressed as the percentage of the initial cells
that formed colonies. Each point was performed at least in
duplicate.
3.2. D12–21 cells fail to induce c-Src acti˝ity upon
EGF stimulation
The mutant EGF-receptor lacking the ABD not
only fails to induce a c-Src translocation, also no
increase in Src activity can be seen in D12–21 cells
after stimulation with EGF. For that, subcellular frac-
tions were prepared and assayed for c-Src auto-kinase
activity or with enolase as a substrate. Although the
basal level of c-src activity varied in the cell lines, it
could be demonstrated that EGF increases the c-Src
activity in the cytosolicrmembrane and cytoskeletal
fractions of HERc13 cells, but not in the D12-21
  . .cells Fig. 1 B and Table 1 . The increase of c-src
activity in the cytoskeletal fraction of EGF-stimulated
HERc13 cells appeared to be the result of a transloca-
tion of c-src protein rather than an increase in spe-
cific activity. As a control the non-transfected parental
 .cell line 3T3 0 , lacking EGF-receptors, was used
and was showing no increase in c-Src activity upon
EGF stimulation.
In cells expressing v-Src, a correlation between
cytoskeleton association of v-Src and cellular trans-
w xformation was found 29,35 . Since also EGF is able
to induce phenotypical transformation in NIH-3T3
w xcells 38,39 , we investigated if this depends on the
translocation of c-Src to the cytoskeleton, using the
lack of c-Src translocation in D12–21 cells as a tool.
In addition, the ABD deletion in these cells did not
interfere with mitogenic responsiveness to EGF data
.not shown . To score for transformational capacity,
NIH-3T3 cells expressing either no EGF-receptors
  ..3T3 0 , increasing amounts of wildtype EGF-recep-
 w xtors HERc13 65 000 receptorsrcell , HER14
w x 250 000 or ABD minus EGF-receptors D12–37
w x w x.40 000 , D12–21 120 000 were analyzed for soft
agar growth with or without the addition of 10 ngrml
EGF. As can be seen from the results in Table 2,
cells expressing the ABD minus EGF-receptor still
are capable of EGF-induced anchorage independent
growth. Cells expressing no EGF-receptors are un-
able to perform EGF-induced soft-agar growth. Fur-
thermore, the extent of soft-agar growth due to EGF
increases with the number of EGF-receptors.
3.3. c-Src binds to actin filaments
The observation that c-Src displayed an increased
cytoskeleton association upon EGF-stimulation
prompted us to investigate whether c-Src associates
to the same cytoskeletal element as the EGF-receptor,
w xwhich is an actin binding protein 5,36 . To determine
the actin binding potential of c-Src, we used a bio-
chemical extraction procedure by which the cyto-
Fig. 3. c-Src is extracted from the cytoskeleton together with
actin filaments. HERc13 cells were extracted with CSK-buffer
containing 0.5% Triton X-100 for 10 min on ice, scraped and
centrifuged at 14 000= g. The supernatant fraction contains
membrane proteins, tubulin and cytosol. The pellet was further
incubated with 0.3 M KI to extract actin-filaments. After centrifu-
gation, the pellet contains nuclei and intermediate filaments. The
actin in the supernatant fraction was repolymerized followed by
one more depolymerizationrrepolymerization cycle. The final
pellet contains actin and actin binding proteins. All fractions were
analysed by western blotting for the presence of c-Src and actin
using mAb a327 and anti-actin antibody respectively. Ts total
cell lysate, CMTscytosolqmembrane proteinsqtubulin, A s
actinqactin binding proteins, INs intermediate filamentsq
nuclei.
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skeleton can be separated into its different compo-
w xnents 36 . Cells were first extracted with 0.5% Triton
X-100 in CSK-buffer at 48C, thereby solubilizing
membrane proteins, cytosol, tubulin and G-actin. The
resulting pellet, containing F-actin, intermediate fila-
ments and nuclei, was further extracted by 0.3 M KI
to remove F-actin. The supernatant, containing the
depolymerized actin, was dialyzed to remove KI
Fig. 4. Immunofluorescence microscopy localization of c-Src and F-actin on HERc13 and D12–21 cells. Quiescent HERc13 and D12–21
 .cells were grown on gelatin-coated glass coverslips, were left untreated yEGF or were treated with 100 ngrml EGF for 20 min
 .qEGF , washed with PBS, fixed with 3% formaldehyde, permeabilized with PBS containing 0.5% Triton X-100 and labelled with
 .  .c-Src-antibody c-Src and phalloidin-TRITC actin . After embedding in mowiol-PPD, cells were viewed on a CLSM and optical
sections were made. Bottomsoptical section at the cell basis, middlesoptical section in medial part of the cell.
( )M.A.G. ˝an der Heyden et al.rBiochimica et Biophysica Acta 1359 1997 211–221218
which results in repolymerization of the actin. This
was followed by one more cycle of depolymeriza-
 .tionrpolymerization. Total cell lysates T ,
 .cytosolrmembrane proteinsrtubulin CMT , actin
 .  .filaments A and intermediate filamentsrnuclei IN
fractions were analyzed by Western blotting for the
presence of c-Src and actin. As shown in Fig. 3,
c-Src and actin is present in total cell lysates, CMT
and actin fractions, but not in IN fractions. So F-actin
and c-Src are co-extracted together. Because c-Src is
still found in the actin-filament fraction after two
cycles of actin depolymerization and repolymeriza-
tion it can be concluded that it binds either directly or
indirectly to actin.
3.4. c-Src translocates together with F-actin in ˝i˝o
To analyze the difference in EGF-induced cyto-
skeleton association between the wildtype and the
ABD-minus cell line in vivo, we performed localiza-
tion studies of endogenous c-Src in these cells and
looked for a colocalization with F-actin. Therefore,
cells were left non-treated or were stimulated with
100 ngrml EGF for 10 min. The cells were subse-
quently fixed, double-stained for c-Src and F-actin
and viewed by CLSM to allow optical sectioning. As
shown in Fig. 4, in resting cells, c-Src associates
predominantly with endosomal membrane structures
located throughout the cell and predominantly con-
centrated in perinuclear rings, which is in agreement
w xwith previous studies 23,24,27 . Optical sections at
the basal level of the cell show no colocalization of
c-Src with stress fibers and at cell-cell contacts. A
colocalization between c-Src and actin-filaments is
found in middle sections, especially in endosomal
regions around the nucleus and to a lesser extent at
the cell edges in both cell types. EGF stimulation
leads to a rearrangement of c-Src to a more tightly
perinuclear localization together with an increased
actin-filament colocalization in this region in HERc13
cells. This EGF-induced rearrangement appeared to
be dependent on the ABD of the EGF-receptor, since
it was less well pronounced in D12–21 cells. These
data demonstrate firstly, that c-Src colocalizes with
actin-filaments, mainly in perinuclear endosomal
structures. Secondly, EGF stimulation leads to an
increase in this perinuclear localization in cells ex-
pressing wildtype EGF-receptors and thirdly, this
process depends on the ABD of the EGF-receptor as
demonstrated in the D12–21 cells. c-Src localization
  ..in control 3T3 0 cells both in presence and absence
of EGF was similar to its localization in HERc13 in
the absence of EGF.
4. Discussion
4.1. c-Src cytoskeletonrF-actin association
We recently demonstrated that EGF induces an
increase in c-Src-cytoskeleton association and activ-
w xity 17 . Using a cell line expressing a mutant EGF-
receptor as a tool, we now demonstrate that the ABD
of the EGF-receptor is required for this translocation.
To investigate whether the lack of increase in c-Src
activity by EGF in the cytoskeleton represents a
general property of the ABD deletion, we measured
the enzymatic activity of PLC, another protein which
w xattaches to the cytoskeleton 37 . As a result of EGF
stimulation cytoskeletal phospholipase C activity in-
creased from 1.3- to 1.4-fold in HERc13 as well as in
 .mutant cells results not shown demonstrating that
the ABD domain of the EGF receptor has a role in
the translocation of some, e.g. c-Src, but not of all
cytoskeleton-associated enzymes. Furthermore, we
show that c-Src associates to the F-actin component
of the cytoskeleton. It remains however, to be estab-
lished if this is a direct or indirect interaction. In
other systems a role for actin in Src cytoskeleton
association was already suggested. In platelets
 .U46619-induced a prostaglandin H2 analogue cyto-
skeleton association of c-Src depends on actin poly-
w xmerization 40 . Localization and biochemical studies
on v-Src suggest that also this molecule is associated
w xto actin 21,29,41–43 . A role for c-Src-actin interac-
w xtion was recently proposed 18 . It was suggested that
c-Src mediates EGF-induced actin remodelling by the
w xactivation of p190RhoGAP 18 .
Our localization data demonstrate that part of the
c-Src is localized on endosomes, mainly around the
w xnucleus as demonstrated before 23,24,27 and at this
place it most prominently colocalizes with F-actin.
Localization studies performed by others show colo-
calization between endosome associated c-Src and
tubulin, mainly at the microtubule organizing center
w x23,27 . This, however, does not exclude colocaliza-
( )M.A.G. ˝an der Heyden et al.rBiochimica et Biophysica Acta 1359 1997 211–221 219
tion with actin.We found that endosomes contain
actin P.M.P. Van Bergen en Henegouwen, unpub-
.lished results which may be part of the membrane
skeleton surrounding the endosomes. The localization
data we described here suggest that c-Src is associ-
ated to the membrane skeleton, specifically in endo-
somes. Furthermore, we did not observe endogenous
c-Src in focal adhesions. Finally, EGF stimulation
might lead to a slight increase in perinuclear c-Src
localization, which is a process that requires the ABD
of the EGF-receptor.
4.2. EGF-induced c-Src acti˝ation
The defects in EGF-induced c-Src cytoskeleton
association and activation in D12–21 cells are proba-
bly correlated. Several studies indicate that the asso-
ciation to the cytoskeleton is important for c-Src
w xactivity 25,29 . The degree of transforming capacity
of v-Src, the viral homologue of c-Src, is related to
w xthe amount of cytoskeleton association 29,35 . Fur-
thermore, thrombin-induced platelet activation results
in c-Src activation together with c-Src association to
w xthe cytoskeleton 40,44–46 . However, we neither
found an effect on EGF-induced transformation Ta-
. w3 xble 2 nor on c-fos mRNA expression or H -thymi-
 .dine incorporation data not shown between cells
expressing wildtype or D12 receptors. This indicates
that these important biological responses to EGF do
not depend on the translocation of c-Src to the cyto-
skeleton. The obvious goal is now to determine the
biological function of this pool of c-Src. A role for
the cytoskeleton associated c-Src could lie in impor-
tant processes like cell movement, cell–cell or cell–
matrix interactions, which all depend on cytoskeletal
rearrangements. Preliminary studies in our laboratory
indeed have shown that EGF receptors lacking the
ABD fail to induce invasion of NIH-3T3 cells into
bone marrow stromal cells in contrast to wild type
w xreceptors 47 .
Deletion of the ABD from the EGF-receptor re-
sults in the loss of a potential autophosphorylation
site at position 992. By using baculovirus expressed,
c-terminal truncated EGF-receptor internal domains
and c-Src SH2 domains, this Y992 site was suggested
to be a binding place for the SH2 domain of c-Src in
w xvitro 48 . However, several observations provide
evidence that this site is at least not required and
probably not involved in a potential c-Src-EGF-re-
ceptor association in vivo. First, Y992 becomes only
phosphorylated in the context of a trunctated receptor
which has lost its major autophosphorylation sites
w x49–52 . Secondly, Sierke demonstrates that the loss
of autophosphorylation sites 1068, 1148 and 1173
strongly decreases the amount of c-Src SH2 domain
association, demonstrating that these autophospho-
rylation sites are also involved in c-Src SH2 domain
binding in vitro. Thirdly, c-Src SH2 binds with a
significant lower affinity to the autophosphorylation
w xsites than rasGAP and p85 48,53 . Fourthly, c-Src
has been shown to bind to the phosphorylated tyro-
w xsine sites 891 and 920 54 .
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